Di Fabio Sara, La Torre Giuseppe
Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.
Vaccines (Basel). 2023 Nov 30;11(12):1791. doi: 10.3390/vaccines11121791.
Following the concerning levels of spread and severity of the infection, on 11 March 2020, the World Health Organisation declared the COVID-19 outbreak a pandemic. In response to the pandemic, governments adopted several mitigation strategies. The pandemic posed a great threat to the Italian healthcare workforce (HW), with Italy being one of the hardest-hit countries. The aim of this study is to estimate the economic burden of COVID-19 on the workforce of a teaching hospital in Central Italy. Two periods are compared: 1 March 2020-9 February 2021 vs. 10 February 2021-31 March 2022. This study is conducted from a societal perspective. The database ( = 3298) of COVID-19-confirmed cases among the HW was obtained from the occupational health office of the hospital. The first entry on the database refers to 1 March 2020. Cost data were used to assess the economic burden of COVID-19 on the hospital workforce. They include two main groups: hourly salaries and medical expenses. The cost of productivity loss, hospital admission, at-home treatments, and contact tracing and screening tests were computed for the first and second periods of the analysis. The total economic burden during the first period is estimated to be around EUR 3.8 million and in the second period EUR 4 million. However, the average cost per person is smaller in the second period (EUR 1561.78) compared to the first one (EUR 5906). In both periods, the cost of productivity loss is the largest component of the economic burden (55% and 57%). The cost of hospital admission decreased by more than 60% in the second period. Outcomes of the analysis suggest that the economic burden of COVID-19 on the HW is higher in the first period of analysis compared to the second period. The main reason could be identified in the shift from more severe and critical confirmed cases to more asymptomatic, mild, and moderate cases. The causes of this shift are not easily detectable. Vaccination, variants of the virus, and an individual's determinants of health could all be causes of the decrease in the economic burden of COVID-19 on the HW. COVID-19 can generate a high economic burden on healthcare workers and, more generally, on HWs. However, a comprehensive estimate of the economic burden of the pandemic needs to integrate the mental health repercussions and the long-term COVID-19 that will become evident in the coming years.
鉴于感染的传播程度和严重程度令人担忧,2020年3月11日,世界卫生组织宣布新冠疫情为大流行病。为应对这一疫情,各国政府采取了多项缓解策略。疫情对意大利医疗工作者构成了巨大威胁,意大利是受影响最严重的国家之一。本研究的目的是评估新冠疫情对意大利中部一家教学医院医疗工作者造成的经济负担。比较了两个时期:2020年3月1日至2021年2月9日与2021年2月10日至2022年3月31日。本研究是从社会角度进行的。医院职业健康办公室提供了医疗工作者中新冠确诊病例的数据库(n = 3298)。数据库中的第一条记录可追溯到2020年3月1日。成本数据用于评估新冠疫情对医院医疗工作者的经济负担。成本数据主要包括两个类别:时薪和医疗费用。计算了分析的第一阶段和第二阶段生产力损失、住院治疗、居家治疗以及接触者追踪和筛查检测的成本。第一阶段的总经济负担估计约为380万欧元,第二阶段为400万欧元。然而,第二阶段的人均成本(1561.78欧元)低于第一阶段(5906欧元)。在两个阶段,生产力损失成本都是经济负担的最大组成部分(分别为55%和57%)。第二阶段的住院治疗成本下降了60%以上。分析结果表明,与第二阶段相比,新冠疫情在第一阶段对医疗工作者造成的经济负担更高。主要原因可能是确诊病例从病情更严重和危急的患者转向了更多无症状、轻症和中症患者。这种转变的原因并不容易察觉。疫苗接种、病毒变种以及个人健康决定因素都可能是新冠疫情对医疗工作者经济负担减轻的原因。新冠疫情会给医护人员,更广泛地说,给医疗工作者带来高昂的经济负担。然而,对疫情经济负担的全面评估需要综合考虑心理健康影响以及未来几年将显现的长期新冠影响。